Jiewei Lin
Impact in
-
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
-
- Circular RNAs in diseases
- RNA modifications and cancer
- Extracellular vesicles in disease
- Epigenetics and DNA Methylation
Papers in
-
- Ubiquitin and proteasome pathways 2
- Epigenetics and DNA Methylation 2
- RNA modifications and cancer 2
- Kruppel-like factors research 1
- Oncology 4
- Pancreatic and Hepatic Oncology Research 4
- Co-authors
- Xiaxing Deng (7 shared papers)Chenghong Peng (4 shared papers)Shuyu Zhai (4 shared papers)Da Fu (3 shared papers)Baiyong Shen (2 shared papers)Jiancheng Wang (2 shared papers)Xinjing Wang (2 shared papers)Minmin Shi (1 shared paper)
In The Last Decade
Jiewei Lin
12 papers receiving 258 citations
Peers
Comparison fields: 5 of 33
- Cancer Research 131
- Molecular Biology 177
- Oncology 44
- Immunology 21
- Geriatrics and Gerontology 3
Countries citing papers authored by Jiewei Lin
This map shows the geographic impact of Jiewei Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiewei Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiewei Lin more than expected).
Fields of papers citing papers by Jiewei Lin
This network shows the impact of papers produced by Jiewei Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiewei Lin. The network helps show where Jiewei Lin may publish in the future.
Co-authors
The 25 scholars most cited alongside Jiewei Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 112 | |
| 2 | 2021 | 30 | |
| 3 | 2023 | 28 | |
| 4 | 2021 | 22 | |
| 5 | 2023 | 13 | |
| 6 | 2022 | 11 | |
| 7 | 2020 | 11 | |
| 8 | 2023 | 9 | |
| 9 | 2019 | 8 | |
| 10 | 2025 | 6 | |
| 11 | 2022 | 6 | |
| 12 | 2019 | 3 |
About Jiewei Lin
Jiewei Lin is a scholar working on Molecular Biology, Oncology, Cancer Research, Nephrology and Cell Biology, having authored 12 papers that have together received 259 indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (4 papers), Ubiquitin and proteasome pathways (2 papers), Epigenetics and DNA Methylation (2 papers), RNA modifications and cancer (2 papers), Cancer-related molecular mechanisms research (2 papers), Kruppel-like factors research (1 paper), Genetics and Neurodevelopmental Disorders (1 paper) and MicroRNA in disease regulation (1 paper). The work is most often cited by research in Cancer Research (131 citations), Molecular Biology (177 citations), Oncology (44 citations), Immunology (21 citations) and Geriatrics and Gerontology (3 citations). Jiewei Lin has collaborated with scholars based in China and Finland. Frequent co-authors include Xiaxing Deng, Chenghong Peng, Shuyu Zhai, Da Fu, Baiyong Shen, Jiancheng Wang, Xinjing Wang, Minmin Shi, Baiyong Shen and Xuelong Wang. Their work appears in journals such as Journal of Experimental & Clinical Cancer Research, Pancreatology, Experimental & Molecular Medicine, Cellular Oncology and Cell Death and Disease.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.